Jersey Shore NJ

Kodiak Sciences Treats First Patients in DAZZLE Pivotal Study of KSI-301 in Wet Age-Related Macular Degeneration

The Press of Atlantic City

Oct 11, 2019

PALO ALTO, Calif., Oct. 10, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic,…

Read the full story at The Press of Atlantic City

Related places

Atlantic City

Kodiak Sciences Treats First Patients in DAZZLE Pivotal Study of KSI-301 in Wet Age-Related Macular Degeneration

Related places

More from Jersey Shore

Flyers Finally Get First Win of the Year Over the Senators

Monmouth Swimming Falls to Seton Hall in Home Opener

Monmouth Men's Tennis Competes at ITA Northeast Regional

Monmouth Rowing Competes at the Head of the Charles Regatta

No. 20/23 Monmouth Football Runs All Over New Hampshire in 42-21 Victory

Monmouth Women's Tennis Falls in Tight Contest to Providence

14-Year-Old Girl Airlifted After E-Bike Crash in Mays Landing

14-Year-Old Girl Airlifted After E-Bike Crash in Mays Landing